For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Drug integrated polymer fibers are used to create implantable textile devices using a combination of resorbable as well as non-resorbable polymers. These devices can be made from different materials and are available in custom sizes and shapes to meet specific biological requirements. With a rise in complexity along with technological innovations, textile devices are being designed to meet a broader range of applications than earlier which will boost the demand of drug integrated polymer fibers. Textiles are being considered as the logical choice for soft tissue repair including hernias, ligaments and tendons due to its fibrous nature of human body.
Scope of the Report:
The worldwide market for Drug Integrated Polymer Fibers is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Drug Integrated Polymer Fibers in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- TissueGen
- Micro Engineering Solutions
- Integrated Polymer Solutions
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Polylactic Acid
- Polydioxanone
- Polycaprolactone
Market Segment by Applications, can be divided into
- Drug Delivery
- Orthopaedic Sutures
- Vascular Stents
- Vascular Grafts
- Dermal Wound Healing
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug Integrated Polymer Fibers product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drug Integrated Polymer Fibers, with price, sales, revenue and global market share of Drug Integrated Polymer Fibers in 2017 and 2018.
Chapter 3, the Drug Integrated Polymer Fibers competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug Integrated Polymer Fibers breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Drug Integrated Polymer Fibers market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Drug Integrated Polymer Fibers sales channel, distributors, customers, research findings and conclusion, appendix and data source.